We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $268M
1-Year Est. Return 158.98%
This Fund
S&P 500
This Quarter Est. Return
+39.3%
1 Year Est. Return
+158.98%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$223M
AUM Growth
+$77.2M
Cap. Flow
+$48M
Cap. Flow %
21.55%
Top 10 Hldgs %
25.3%
Holding
464
New
223
Increased
67
Reduced
60
Closed
103

Sector Composition

1 Healthcare 52.36%
2 Technology 13.57%
3 Financials 11.27%
4 Communication Services 4.48%
5 Energy 3.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIIB icon
126
Biogen
BIIB
$30.4B
$506K 0.23%
+2,874
New +$470K
LPLA icon
127
LPL Financial
LPLA
$26B
$501K 0.23%
+1,403
New +$496K
MOD icon
128
Modine Manufacturing
MOD
$12.2B
$499K 0.22%
+3,735
New +$556K
THC icon
129
Tenet Healthcare
THC
$16.8B
$497K 0.22%
2,499
-3,957
-61% -$800K
EW icon
130
Edwards Lifesciences
EW
$49.4B
$491K 0.22%
+5,761
New +$473K
TSM icon
131
TSMC
TSM
$2.07T
$486K 0.22%
+1,600
New +$469K
VTYX
132
DELISTED
Ventyx Biosciences
VTYX
$484K 0.22%
53,642
+37,347
+229% +$279K
MDT icon
133
Medtronic
MDT
$106B
$481K 0.22%
+5,009
New +$487K
ARGX icon
134
argenx
ARGX
$53.8B
$474K 0.21%
+564
New +$483K
ANNX icon
135
Annexon
ANNX
$950M
$470K 0.21%
+93,657
New +$358K
VRTX icon
136
CALL
Vertex Pharmaceuticals
VRTX
$123B
$467K 0.21%
+236
New +$102K
TERN
137
CALL
DELISTED
Terns Pharmaceuticals
TERN
$464K 0.21%
147
-373
-72% -$8.62K
GDS icon
138
GDS Holdings
GDS
$6.24B
$463K 0.21%
+13,271
New +$459K
GLW icon
139
Corning
GLW
$133B
$462K 0.21%
+5,276
New +$454K
MNKD icon
140
MannKind Corp
MNKD
$1.25B
$462K 0.21%
81,463
+32,201
+65% +$177K
HSAI
141
Hesai Group
HSAI
$2.36B
$453K 0.2%
20,226
-23,000
-53% -$503K
ICLR icon
142
Icon
ICLR
$13.1B
$451K 0.2%
+2,474
New +$441K
EHTH icon
143
eHealth
EHTH
$47.3M
$449K 0.2%
97,606
-10,500
-10% -$46.3K
IONS icon
144
CALL
Ionis Pharmaceuticals
IONS
$8.99B
$432K 0.19%
285
+56
+24% +$4.22K
GKOS icon
145
Glaukos
GKOS
$9.21B
$426K 0.19%
+3,770
New +$360K
GDOT icon
146
Green Dot
GDOT
$760M
$419K 0.19%
+32,744
New +$407K
CRL icon
147
Charles River Laboratories
CRL
$10.8B
$419K 0.19%
+2,099
New +$381K
PRAX icon
148
Praxis Precision Medicines
PRAX
$8.77B
$415K 0.19%
+1,407
New +$262K
BCRX icon
149
BioCryst Pharmaceuticals
BCRX
$2.36B
$403K 0.18%
+51,701
New +$374K
DNTH icon
150
Dianthus Therapeutics
DNTH
$5.77B
$401K 0.18%
+9,739
New +$378K

Similar funds

Persistent Asset Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Persistent Asset Partners held 464 positions worth $223M, up 53% from $145M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Persistent Asset Partners deployed $48M of net new capital in Q4 2025, opening 223 new positions and adding to 67 existing holdings. Its largest new stake was Molina Healthcare: 51,285 shares worth $8.9M.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 49% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was UnitedHealth, an estimated $3.15M trimmed.

  • Persistent Asset Partners's largest Q4 2025 buy was Molina Healthcare: 51,285 shares worth $8.9M.
  • Persistent Asset Partners added most to Elevance Health in Q4 2025, an estimated $5.15M increase.
  • Persistent Asset Partners's biggest Q4 2025 reduction was UnitedHealth, cutting an estimated $3.15M.
  • Persistent Asset Partners fully exited iShares 7-10 Year Treasury Bond ETF in Q4 2025, selling an estimated $4.82M.
  • Persistent Asset Partners's ten largest holdings make up 25% of its $223M portfolio in Q4 2025.
  • Persistent Asset Partners opened 223 new positions and closed 103 in Q4 2025.
  • Persistent Asset Partners's portfolio value rose 53% quarter-over-quarter to $223M.

Based on Persistent Asset Partners's 13F filing for Q4 2025, filed 17 Feb 2026.